Articles

Utility of Molecular and Structural Brain Imaging to Predict Progression from MCI to Dementia

Lan, Martin J; Ogden, R. Todd; Kumar, Dileep; Stern, Yaakov; Parsey, Ramin V; Pelton, Gregory H; Rubin-Falcone, Harry; Pradhaban, Gnanavalli; Zanderigo, Francesca; Miller, Jeffrey M; Mann, J John; Devanand, D P

This project compares three neuroimaging biomarkers to predict progression to dementia in subjects with mild cognitive impairment (MCI). Eighty-eight subjects with MCI and 40 healthy controls (HCs) were recruited. Subjects had a 3T magnetic resonance imaging (MRI) scan, and two positron emission tomography (PET) scans, one with Pittsburgh compound B ([11C]PIB) and one with fluorodeoxyglucose ([18F]FDG). MCI subjects were followed for up to 4 years and progression to dementia was assessed on an annual basis. MCI subjects had higher [11C]PIB binding potential (BPND) than HCs in multiple brain regions, and lower hippocampus volumes. [11C]PIB BPND, [18F]FDG standard uptake value ratio (SUVR) and hippocampus volume were associated with time to progression to dementia using a Cox proportional hazards model.

Subjects

Files

  • thumnail for Lan et al. - 2017 - Utility of Molecular and Structural Brain Imaging .pdf Lan et al. - 2017 - Utility of Molecular and Structural Brain Imaging .pdf application/pdf 279 KB Download File

Also Published In

More About This Work

Academic Units
Neurology
Published Here
February 11, 2022